Current Rating Overview
On 13 Nov 2025, Jeevan Scientific Technology Ltd's rating was revised to 'Sell' from a previous 'Strong Sell' status, reflecting a notable improvement in its Mojo Score from 29 to 46. Despite this positive shift, the 'Sell' rating indicates that the stock remains a cautious choice for investors, suggesting potential risks outweigh the rewards at present. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals.
Quality Assessment
As of 20 May 2026, the company’s quality grade remains below average. This is primarily due to its weak long-term fundamental strength, highlighted by a concerning compound annual growth rate (CAGR) of -169.69% in operating profits over the past five years. Such a steep decline signals persistent challenges in generating sustainable earnings. Additionally, the average Return on Equity (ROE) stands at 9.56%, which is modest and indicates limited profitability relative to shareholders’ funds. These factors collectively temper confidence in the company’s operational robustness.
Valuation Considerations
Currently, Jeevan Scientific Technology Ltd is classified as risky from a valuation standpoint. The company has recorded negative operating profits, with an EBIT of Rs. -1.66 crore, underscoring ongoing profitability issues. Despite the stock’s impressive price appreciation—delivering a 97.67% return over the past year as of 20 May 2026—this growth has not been matched by financial performance. In fact, profits have deteriorated by 378% during the same period. The stock’s valuation metrics suggest it is trading at levels that may not be justified by its underlying earnings, increasing the risk profile for investors.
Financial Trend Analysis
The financial grade for Jeevan Scientific Technology Ltd is positive, reflecting some encouraging trends in recent periods. The stock has shown strong momentum with returns of +35.80% over six months and +30.30% year-to-date as of 20 May 2026. This indicates that market sentiment remains favourable despite fundamental weaknesses. However, the negative operating profit trend and volatile earnings growth highlight the need for caution, as the company’s financial health has not stabilised sufficiently to support a more optimistic rating.
Technical Outlook
Technically, the stock is rated bullish, signalling positive price momentum and potential for further gains in the near term. The recent price movements show resilience, with a 3-month return of +18.61% and a modest 1-month gain of +1.20%. The day change on 20 May 2026 was a slight decline of -0.13%, indicating some short-term volatility. This bullish technical stance may attract traders looking for momentum plays, but it should be weighed against the company’s fundamental challenges.
What the 'Sell' Rating Means for Investors
The 'Sell' rating from MarketsMOJO suggests that investors should approach Jeevan Scientific Technology Ltd with caution. While the stock has demonstrated strong price appreciation recently, the underlying financials reveal significant risks, including negative operating profits and weak long-term growth. The rating advises that the stock may not be suitable for risk-averse investors or those seeking stable earnings growth. Instead, it may appeal to speculative investors who are comfortable with volatility and are looking to capitalise on technical momentum rather than fundamental strength.
Summary of Key Metrics as of 20 May 2026
- Mojo Score: 46.0 (Sell Grade)
- Market Capitalisation: Microcap segment
- Operating Profit CAGR (5 years): -169.69%
- Return on Equity (avg): 9.56%
- EBIT: Rs. -1.66 crore (negative)
- Stock Returns: 1 Year +97.67%, 6 Months +35.80%, YTD +30.30%
- Technical Grade: Bullish
Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!
- - Clear entry/exit targets
- - Target price revealed
- - Detailed report available
Investor Takeaway
Investors considering Jeevan Scientific Technology Ltd should carefully weigh the current 'Sell' rating against their risk tolerance and investment horizon. The stock’s recent price gains are encouraging but are not supported by strong fundamentals, which remain a concern. The negative operating profits and weak long-term growth trend suggest that the company faces structural challenges that may limit sustainable value creation. Meanwhile, the bullish technical indicators could offer short-term trading opportunities but do not mitigate the fundamental risks.
For those seeking exposure to the healthcare services sector, it may be prudent to explore companies with stronger financial health and more stable earnings profiles. Jeevan Scientific Technology Ltd’s current valuation and financial trend imply that it remains a speculative investment rather than a core portfolio holding.
Conclusion
In summary, Jeevan Scientific Technology Ltd’s 'Sell' rating as of 13 Nov 2025 reflects a cautious stance grounded in below-average quality, risky valuation, positive yet volatile financial trends, and bullish technical signals. As of 20 May 2026, the stock’s strong price performance contrasts with its fundamental weaknesses, underscoring the importance of a balanced approach for investors. Monitoring future earnings reports and operational improvements will be key to reassessing the stock’s outlook going forward.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
